[HTML][HTML] Current understanding of neurofibromatosis type 1, 2, and schwannomatosis

R Tamura - International journal of molecular sciences, 2021 - mdpi.com
Neurofibromatosis (NF) is a neurocutaneous syndrome characterized by the development of
tumors of the central or peripheral nervous system including the brain, spinal cord, organs …

Neurofibromatosis type 1

DH Gutmann, RE Ferner, RH Listernick… - Nature Reviews …, 2017 - nature.com
Neurofibromatosis type 1 is a complex autosomal dominant disorder caused by germline
mutations in the NF1 tumour suppressor gene. Nearly all individuals with neurofibromatosis …

[HTML][HTML] Neurofibromatosis type 1: a multidisciplinary approach to care

AC Hirbe, DH Gutmann - The Lancet Neurology, 2014 - thelancet.com
Neurofibromatosis type 1 is a relatively common inherited disorder. Patients have a high
predisposition to develop both benign and malignant tumours. Although many …

Comparison of cancer prevalence in patients with neurofibromatosis type 1 at an academic cancer center vs in the general population from 1985 to 2020

JP Landry, KL Schertz, YJ Chiang, AD Bhalla… - JAMA Network …, 2021 - jamanetwork.com
Importance Neurofibromatosis type 1 (NF1) is a complex genetic disorder that is associated
with not only neurofibromas, but also an increased susceptibility to other neoplasms …

[HTML][HTML] Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966

C Bergqvist, A Servy, L Valeyrie-Allanore… - Orphanet Journal of …, 2020 - Springer
Neurofibromatosis type 1 is a relatively common genetic disease, with a prevalence ranging
between 1/3000 and 1/6000 people worldwide. The disease affects multiple systems with …

[HTML][HTML] ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1

C Carton, DG Evans, I Blanco, RE Friedrich… - …, 2023 - thelancet.com
Summary Background Neurofibromatosis type 1 (NF1) is a multisystem genetic disorder,
predisposing development of benign and malignant tumours. Given the oncogenic potential …

Malignant peripheral nerve sheath tumours in neurofibromatosis 1

DGR Evans, ME Baser, J McGaughran… - Journal of medical …, 2002 - jmg.bmj.com
Background: Cross sectional studies have shown that 1-2% of patients with
neurofibromatosis 1 (NF1) develop malignant peripheral nerve sheath tumours (MPNST) …

[HTML][HTML] Clinical and genetic aspects of neurofibromatosis 1

K Jett, JM Friedman - Genetics in Medicine, 2010 - Elsevier
Neurofibromatosis 1 is an autosomal dominant disorder characterized by multiple café-au-
lait spots, axillary and inguinal freckling, multiple cutaneous neurofibromas, and iris Lisch …

[PDF][PDF] Incidence and mortality of neurofibromatosis: a total population study in Finland

E Uusitalo, J Leppävirta, A Koffert… - The Journal of …, 2015 - academia.edu
2005; Evans et al., 2010; Supplementary Table S1 online). NF2 is markedly less common
than NF1. The reported incidences of NF2 have varied between 1/33,000 (Evans et al …

[HTML][HTML] Neurofibromatosis 1

JM Friedman - 2022 - europepmc.org
Neurofibromatosis 1 (NF1) is a multisystem disorder characterized by multiple café au lait
macules, intertriginous freckling, multiple cutaneous neurofibromas, and learning disability …